Metformin is associated with a reduction in the number of COVID-19 cases

Published Date: 08 Mar 2023

The latest data on metformin in COVID show benefits in the disease.

Read Full News

Latest News

US Will Nearly Double Financial Commitment to Ebola Response

The U.S. State Department on Wednesday nearly doubled its financial commitment to the Ebola response in eastern Democratic Republic of Congo, announcing ⁠plans to provide an...

US FDA Approves First MRNA Flu Shot From Moderna

The U.S. Food and Drug Administration has approved Moderna's flu vaccine for people aged 50 and older, the company said on Wednesday, marking the first approval ⁠of a...

Baseline Steroids Fail to Benefit Bronchiectasis Patients

Observational data show an association between baseline inhaled corticosteroid use and poor outcomes after a year.

Senate Confirms Schwartz to Lead CDC

The long-time public servant is leaving a position with UnitedHealth to return to the health agency.

Congo Intercepts Boat That Carried Suspected Ebola Case

Congolese health authorities have intercepted a boat carrying 200 people to the capital ⁠Kinshasa after a passenger who had disembarked earlier died on July 25. after...

CDC Expands Largest Known Cyclosporiasis Outbreak to 15 States, Washington Post Reports

The U.S. CDC is adding six more states to the cyclosporiasis outbreak linked to iceberg lettuce, widening ⁠the number of affected states to 15, the Washington Post reported...

Todays Updates

Jazz Seeks Second-Line Lurbinectedin SCLC Withdrawal

The planned label change follows failure of lurbinectedin to improve overall survival in the phase 3 postmarketing trial; the first-line maintenance indication remains unaffected.

Todays Updates

Jazz Seeks Second-Line Lurbinectedin SCLC Withdrawal

The planned label change follows failure of lurbinectedin to improve overall survival in the phase 3 postmarketing trial; the first-line maintenance indication remains unaffected.

Latest News

The U.S. State Department on Wednesday nearly doubled its financial commitment to the Ebola response in eastern Democratic Republic of Congo, announcing ⁠plans to provide an...

The U.S. Food and Drug Administration has approved Moderna's flu vaccine for people aged 50 and older, the company said on Wednesday, marking the first approval ⁠of a...

Observational data show an association between baseline inhaled corticosteroid use and poor outcomes after a year.

The long-time public servant is leaving a position with UnitedHealth to return to the health agency.

Congolese health authorities have intercepted a boat carrying 200 people to the capital ⁠Kinshasa after a passenger who had disembarked earlier died on July 25. after...

The U.S. CDC is adding six more states to the cyclosporiasis outbreak linked to iceberg lettuce, widening ⁠the number of affected states to 15, the Washington Post reported...

News All Time

Cyclosporiasis Cases in Michigan Surpass 10,000 in Ongoing Outbreak

Michigan health officials reported 10,077 cases of cyclosporiasis on Wednesday, an increase of 397 ⁠cases since their last update a day earlier.

IGRA vs TST: Which Test Better Detects Latent Tuberculosis?

Tuberculin skin test positivity exceeds interferon-gamma release assay positivity among healthcare workers and first responders, a meta-analysis finds.

UK Reports Rise in Cyclospora Infections Linked to Mexico Travel

The UK Health Security Agency (UKHSA) said on Thursday it was seeing a sharp rise in cyclospora infections among travellers ⁠returning from Mexico and urged people to follow...

US Lawmakers Press Health Secretary Robert F. Kennedy Jr. on Vaccine Settlement

(Corrects spelling of attorney's name in paragraphs 12, 13)

Michigan Reports 9,253 Cyclosporiasis Cases as Infection Outbreak Expands

Michigan health officials reported 9,253 cases of cyclosporiasis on Monday, an increase of 1,077 cases since their last update on Friday, as ⁠the intestinal infection...

Uganda Declares End to Latest Ebola Outbreak

Uganda's health minister declared the country Ebola-free following the nation's latest ⁠outbreak of the viral hemorrhagic disease that infected 20 people and killed two of them.

A Day in the Life Of Congo's Overstretched Ebola Surveillance Teams

On a good day, there are only four cars available to ferry surveillance teams round the city of Bunia, the epicentre of an Ebola outbreak surging through the Democratic...

Low-Dose CT and PCR Fail to Cut Antibiotic Use in Pneumonia

In hospitalized adults with community-acquired pneumonia, low-dose chest CT does not lower broad-spectrum antibiotic use, whereas multiplex polymerase chain reaction may provide a modest benefit.

US FDA Widens Investigation Into Cyclosporiasis Cases to Four More States

The U.S. FDA and the CDC are widening their investigation into a cyclosporiasis outbreak linked to shredded iceberg lettuce from central Mexico after identifying ⁠cases in...

Nearly 3,000 Confirmed Infected With Ebola in Congo After Data Review

The number of people confirmed infected with Ebola in the Democratic ⁠Republic of Congo was heading towards 3,000 on Friday after officials reviewed data ⁠in two of the...

Patients Are Self-Prescribing DoxyPEP. Is This a Problem?

Syphilis cases are rising across Europe. Many are turning to doxycycline to prevent it. Is antimicrobial resistance a concern?

Merck Licenses Experimental HIV Pill to Generic Makers in 129 Countries

Merck said on Friday it signed seven voluntary licensing agreements with generic drug manufacturers to make and sell ⁠lower-cost versions of its experimental once-monthly...

Pfizer's Prostate Cancer Drug Combination Gets US FDA Priority Review

Pfizer said on Wednesday the U.S. Food and Drug Administration had granted priority review to ⁠its application seeking expanded approval for its prostate cancer treatment...

Proton Pump Inhibitors Boost Exacerbations in Bronchiectasis

Consider a deprescribing trial in patients without chronic indications.

Expected Practice Guidelines Boost Oral/IV Antibiotic Use

Expected practice guidelines increase oral or long-acting intravenous antibiotic use and lower readmission rates, study shows.

Carl H. June on CAR-T’s Next Frontier: Autoimmune Disease

In an interview, Carl H. June discusses how CAR-T therapy transformed blood cancer treatment, the challenges of extending it to solid tumors, and why autoimmune disease may be its next major frontier.

Recommended News For You

Losing a reward can affect your motivation and performance.

Do Anatomy Atlases Reflect Social Inequalities?

iPSC-based vaccines: A new hope for preventing and treating colorectal cancer

Can patients receiving immunotherapy for cancer benefit from taking vitamin D supplements?

The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.

Adipocytes in the bone marrow offer early indicators of the development of multiple myeloma from MGUS.

Breast cancer: Why it's difficult to treat and what new approaches are on the horizon

Recommended Articles For You

The Benefits and Side Effects of Vidaza Syndrome  

Circulating Tumor DNA in Early Cancer Detection 

Strategic Applications in Hematology in Clinical Decision-Making 

Unlocking the Mystery of Granulomas: A Closer Look at the Causes and Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Non-Hodgkin lymphomas that are indolent have been linked to psychological distress.

2.

De-escalation Misses the Mark in Inflammatory Breast Cancer

3.

Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular Lymphoma

4.

Hereditary cancer has a rare and underreported cause.

5.

Morning Immunotherapy Does Not Boost Lung Cancer Survival

1.

Everything You Need to Know About RDW-CV: A Comprehensive Guide 

2.

Precision Medicine in Modern Cancer Therapy

3.

Exploring Innovative Solutions for Infantile Hemangioma Treatment

4.

Understanding Lymphedema: Symptoms, Causes, and Treatment 

5.

Emerging Advances in Hematology and Quality Improvement

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

1.

Efficient Management of First line ALK-rearranged NSCLC - Part II

2.

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

3.

CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot